68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

Clinical trial NCT01396382 · COMPLETED

Trial details

NCT number: NCT01396382
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Carcinoma

Start date: 2010-03-01
Primary completion: 2014-05-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.